R01 AR049025/AR/NIAMS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2004	1
2007	2
2008	2
2009	4
2010	4
2011	8
2012	3
2013	1
2014	1
2015	1
2016	1
2017	1
2021	0

1

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

Varga J, Abraham D. Varga J, et al. J Clin Invest. 2007 Mar;117(3):557-67. doi: 10.1172/JCI31139. J Clin Invest. 2007. PMID: 17332883 Free PMC article. Review.

2

Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target.

Marangoni RG, Masui Y, Fang F, Korman B, Lord G, Lee J, Lakota K, Wei J, Scherer PE, Otvos L, Yamauchi T, Kubota N, Kadowaki T, Asano Y, Sato S, Tourtellotte WG, Varga J. Marangoni RG, et al. Sci Rep. 2017 Jun 30;7(1):4397. doi: 10.1038/s41598-017-04162-1. Sci Rep. 2017. PMID: 28667272 Free PMC article.

3

Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Bhattacharyya S, Wei J, Varga J. Bhattacharyya S, et al. Nat Rev Rheumatol. 2011 Oct 25;8(1):42-54. doi: 10.1038/nrrheum.2011.149. Nat Rev Rheumatol. 2011. PMID: 22025123 Free PMC article. Review.

4

Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis.

Wei J, Bhattacharyya S, Varga J. Wei J, et al. Curr Opin Rheumatol. 2010 Nov;22(6):671-6. doi: 10.1097/BOR.0b013e32833de1a7. Curr Opin Rheumatol. 2010. PMID: 20693905 Free PMC article. Review.

5

Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan.

Allen JA, Peterson A, Sufit R, Hinchcliff ME, Mahoney JM, Wood TA, Miller FW, Whitfield ML, Varga J. Allen JA, et al. Arthritis Rheum. 2011 Nov;63(11):3633-9. doi: 10.1002/art.30514. Arthritis Rheum. 2011. PMID: 21702023 Free PMC article.

6

Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signalling.

Mutlu GM, Budinger GR, Wu M, Lam AP, Zirk A, Rivera S, Urich D, Chiarella SE, Go LH, Ghosh AK, Selman M, Pardo A, Varga J, Kamp DW, Chandel NS, Sznajder JI, Jain M. Mutlu GM, et al. Thorax. 2012 Feb;67(2):139-46. doi: 10.1136/thoraxjnl-2011-200717. Epub 2011 Sep 15. Thorax. 2012. PMID: 21921091 Free PMC article.

7

SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis.

Akamata K, Wei J, Bhattacharyya M, Cheresh P, Bonner MY, Arbiser JL, Raparia K, Gupta MP, Kamp DW, Varga J. Akamata K, et al. Oncotarget. 2016 Oct 25;7(43):69321-69336. doi: 10.18632/oncotarget.12504. Oncotarget. 2016. PMID: 27732568 Free PMC article.

8

A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.

Wei J, Zhu H, Komura K, Lord G, Tomcik M, Wang W, Doniparthi S, Tamaki Z, Hinchcliff M, Distler JH, Varga J. Wei J, et al. Ann Rheum Dis. 2014 Feb;73(2):446-54. doi: 10.1136/annrheumdis-2012-202716. Epub 2013 Mar 20. Ann Rheum Dis. 2014. PMID: 23515440 Free PMC article.

9

Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.

Wei J, Bhattacharyya S, Tourtellotte WG, Varga J. Wei J, et al. Autoimmun Rev. 2011 Mar;10(5):267-75. doi: 10.1016/j.autrev.2010.09.015. Epub 2010 Sep 21. Autoimmun Rev. 2011. PMID: 20863909 Free PMC article.

10

Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.

Wei J, Fang F, Lam AP, Sargent JL, Hamburg E, Hinchcliff ME, Gottardi CJ, Atit R, Whitfield ML, Varga J. Wei J, et al. Arthritis Rheum. 2012 Aug;64(8):2734-45. doi: 10.1002/art.34424. Arthritis Rheum. 2012. PMID: 22328118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results